Vertigo and dizziness
Conditions
Interventions
Observation group:None
Sponsors
Eye & ENT hospital of Fudan University
Eligibility
Sex/Gender
All
Age
8 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Age 8–18 years old; 2. Chief complaint of dizziness or vertigo, meeting at least one of the following: (1) Moderate vestibular symptom attacks >=3 times, severe vestibular symptom attacks >=2 times; (2) Symptoms lasting more than 1 month; Note: Moderate vestibular symptoms refer to symptoms that interfere with daily activities but still allow them to be performed; severe vestibular symptoms refer to symptoms that prevent daily activities. 3. The participant and their legal guardian are able to understand the purpose and procedures of the study, voluntarily participate, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals with severe developmental or cognitive disorders, cardiovascular and cerebrovascular diseases, cervical spine disease, spinal cord injury, or other reasons deemed by the researchers as unsuitable for enrollment; 2. Recent use of immunosuppressants, glucocorticoids, antiviral drugs (only for VN patients), or metabolism-affecting drugs (such as hypoglycemic drugs, lipid-lowering drugs) within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of dizziness/vertigo symptoms over 6 months;decrease in frequency of attacks; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score changes of DHI-PC and PVSQ; | — |
Countries
China
Contacts
Public ContactWenyan Li
Eye & ENT hospital of Fudan University
Outcome results
None listed